Literature DB >> 8008736

Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.

G Lanza1, I Maestri, M R Ballotta, A Dubini, L Cavazzini.   

Abstract

Nuclear DNA content was determined in 123 colorectal adenocarcinomas by flow cytometry using multiple frozen tumor samples. Thirty-three (26.8%) carcinomas were classified as diploid and 90 as aneuploid (73.2%). Presence of DNA aneuploidy was found to be unrelated to tumor stage and grade of differentiation and to other histopathological variables such as pattern of growth, degree of peritumoral lymphocytic infiltration, and venous invasion. However, multiploid tumors (20/123, 16.3%) were more frequently noted in advanced stages of disease (Stages III and IV, P < 0.025) and more often showed unfavorable histopathological features, especially an infiltrating pattern of growth (P < 0.05), compared with diploid and single aneuploid carcinomas. Nuclear DNA content was found to be closely related to tumor site. Carcinomas of the proximal (right and transverse) colon were more frequently diploid (19/43, 44.2% versus 14/80, 17.5%--P < 0.005) and more often displayed a DNA index (DI, defined as the ratio of the DNA content of neoplastic cells to that of normal cells) < or = 1.20 (27/43, 62.8% versus 19/80, 23.7%--P < 0.001) than did tumors localized distally to the splenic flexure. Nuclear DNA content was also found to be related to tumor type. A high proportion of mucinous adenocarcinomas showed DI values < or = 1.20 (14/21, 66.7%); conversely only 32 of 102 (31.4%) non-mucinous adenocarcinomas had a DI < or = 1.20 (P < 0.01). The nuclear DNA content of mucinous adenocarcinomas seemed to be independent of tumor location.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008736

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

1.  DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.

Authors:  J Sikora; G Dworacki; J Zeromski
Journal:  Lung       Date:  1996       Impact factor: 2.584

2.  Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data.

Authors:  Jennifer M Weiss; Patrick R Pfau; Erin S O'Connor; Jonathan King; Noelle LoConte; Gregory Kennedy; Maureen A Smith
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

3.  Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab.

Authors:  Christopher G Smith; David Fisher; Bart Claes; Timothy S Maughan; Shelley Idziaszczyk; Gilian Peuteman; Rebecca Harris; Michelle D James; Angela Meade; Bharat Jasani; Richard A Adams; Sarah Kenny; Richard Kaplan; Diether Lambrechts; Jeremy P Cheadle
Journal:  Clin Cancer Res       Date:  2013-06-05       Impact factor: 12.531

Review 4.  The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.

Authors:  Masashi Yahagi; Koji Okabayashi; Hirotoshi Hasegawa; Masashi Tsuruta; Yuko Kitagawa
Journal:  J Gastrointest Surg       Date:  2015-11-16       Impact factor: 3.452

5.  DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: analysis of prognosis and current trends.

Authors:  Han-Shiang Chen; Shyr-Ming Sheen-Chen; Chen-Chang Lu
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

6.  Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.

Authors:  Jennifer M Weiss; Jessica Schumacher; Glenn O Allen; Heather Neuman; Erin O'Connor Lange; Noelle K Loconte; Caprice C Greenberg; Maureen A Smith
Journal:  Ann Surg Oncol       Date:  2014-03-19       Impact factor: 5.344

7.  Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients.

Authors:  Sepideh Gholami; Susan Stewart; Nancy Kemeny; Mithat Gönen; Bas Groot Koerkamp; Andrea Cercek; Peter Kingham; Vinod Balachandran; Peter Allen; Ronald DeMatteo; Alice Wei; Louise Connell; Jeffrey Drebin; William Jarnagin; Michael D'Angelica
Journal:  Ann Surg Oncol       Date:  2020-11-23       Impact factor: 4.339

8.  Second primary colorectal cancer after the initial primary colorectal cancer.

Authors:  Lin Yang; Zhenchong Xiong; Qian Kun Xie; Wenzhuo He; Shousheng Liu; Pengfei Kong; Chang Jiang; Xiaojun Xia; Liangping Xia
Journal:  BMC Cancer       Date:  2018-09-27       Impact factor: 4.430

Review 9.  Is mucinous carcinoma of the colorectum a distinct genetic entity?

Authors:  C Hanski
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

10.  Better survival in right-sided versus left-sided stage I - III colon cancer patients.

Authors:  Rene Warschkow; Michael C Sulz; Lukas Marti; Ignazio Tarantino; Bruno M Schmied; Thomas Cerny; Ulrich Güller
Journal:  BMC Cancer       Date:  2016-07-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.